TIS 0.00% 0.0¢ tissue therapies limited

Time to take stock (take that what ever way you want)Negitive,...

  1. 261 Posts.
    Time to take stock (take that what ever way you want)
    Negitive, short term share price drop.
    No early sales

    Positives
    Shelf life expriment showing longer life.
    There-fore larger batch production, so cheaper to produce.
    More profit.
    Sales start to a much bigger customer base,
    More profit.
    Patients in Australia get acces sooner, My uncle smiles.
    May help USA process (total guess).
    So bottom line is we will be finacially better off at the end of 2013.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.